14M Genomics is a cancer diagnostic company, based in Cambridge UK and working in partnership with the Wellcome Trust Sanger Institute, to enrich the understanding of the role of cancer genes in the biology of disease. We employ state-of-the-art sequencing and analytical tools, coupled with an in-depth understanding of cancer biology, to reveal associations between tumour genomics and the clinical path of the individual patients. Our processes will generate linked genomic and clinical datasets that will provide a reference enabling the diagnostic and prognostic stratification of patients and ultimately guide treatment options for the oncologist and patient alike.
We provide extraordinary career opportunities for talented individuals, who will have the opportunity to work with highly experienced leaders in science and business with proven track records in building successful genomic and diagnostic businesses. Our success depends on the quality, experience and ambition of the individuals that join our team.